Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Bacteraemia with an MBL-producing Klebsiella pneumoniae : treatment and the potential role of cefiderocol heteroresistance

Journal of Antimicrobial Chemotherapy(2022)10.1093/jac/dkac197Source: DataRank Database

Bacteraemia with an MBL-producing Klebsiella pneumoniae : treatment and the potential role of cefiderocol heteroresistance is a research paper published in Journal of Antimicrobial Chemotherapy (2022). On theSindex it has a DataRank of 0. It has been cited 15 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access15 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 0.71)OA: greenTopics (43)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Danielle Barrios Steed ORCID,Eileen M. Burd ORCID,Tugba Ozturk ORCID,Michelle H. Davis ORCID,Sarah W. Satola ORCID

Live enrichment

PubMed:35726616 PMC:PMC9989728 OpenAlex:https://openalex.org/W4283206134

National Institutes of Health

Grant: UL1TR002378

National Institutes of Health

Grant: TL1TR002382

National Institutes of Health

Grant: Al158080

National Institutes of Health

Grant: 5UL1TR002378-09

Georgia Clinical & Translational Science Alliance (Georgia CTSA)

National Institutes of Health

Grant: 5TL1TR002382-05

J: NRSA Training Core

Burroughs Wellcome Fund

National Center for Advancing Translational Sciences

FWCI

0.71

Citation Percentile

0.6%

Citation Trend

2022

2023

2024

2025

2026

greenLicense: OUP Standard Publication Reuse

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9989728

publisherhttps://academic.oup.com/jac/article-pdf/77/9/2569/50448298/dkac197.pdf

journalhttps://doi.org/10.1093/jac/dkac197

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35726616

Fields of Study

Antibiotic Resistance in BacteriaBacterial Identification and Susceptibility TestingAntibiotics Pharmacokinetics and Efficacy0301 basic medicine03 medical and health sciencesAnti-Bacterial AgentsBacteremiaCephalosporinsHumansKlebsiella InfectionsKlebsiella pneumoniaeMicrobial Sensitivity Testsbeta-LactamasesCefiderocol

MeSH Terms

CefiderocolAnti-Bacterial Agentsbeta-LactamasesCephalosporinsHumansKlebsiella InfectionsKlebsiella pneumoniaeMicrobial Sensitivity TestsBacteremia

Keywords

Klebsiella pneumoniaeAntibiotic resistanceAntibioticsAntimicrobialBiologyDrug resistanceMedicineMicrobiologyIntensive care medicineGeneticsGeneEscherichia coliHumansBacteremiaCefiderocolMicrobial Sensitivity Testsbeta-LactamasesAnti-Bacterial AgentsCephalosporinsKlebsiella Infections

Sustainable Development Goals

SDG 0: Good health and well-being